
Hematologic Oncology Update
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Get every episode summarized
Each time Hematologic Oncology Update publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Episodes (205)
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Rec...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non...
Hematologic Oncology Update
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Mul...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase M...
Hematologic Oncology Update
What Clinicians Want to Know About Toxicity Considerations Associated with BTK I...
Hematologic Oncology Update
Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodie...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle...
Hematologic Oncology Update
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic...
Hematologic Oncology Update
Inside the Issue: Integrating Bispecific Antibodies into the Management of Multi...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Special Edition — What I Tell My Patients Abou...
Hematologic Oncology Update
Inside the Issue: Novel Agents, Approaches and Strategies in the Management of H...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Immune Thrombocytopenia Edition
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinu...
Hematologic Oncology Update
Meet The Professor: The Current and Future Management of Non-Hodgkin Lymphoma
Hematologic Oncology Update
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related...
Hematologic Oncology Update
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Key Presentations from the 64th American Socie...
Hematologic Oncology Update
Oncology Today with Dr Neil Love — Key Presentations from the 64th American Soci...
Hematologic Oncology Update
Recent Advances and Future Directions in Chronic Lymphocytic Leukemia and Lympho...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Key Presentations in Hodgkin and Non-Hodgkin L...
Hematologic Oncology Update
Inside the Issue — Optimizing the Management of Adverse Events Associated with B...
Hematologic Oncology Update
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data...
Hematologic Oncology Update
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neopla...
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma
Hematologic Oncology Update
Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia an...
Hematologic Oncology Update
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data...
Hematologic Oncology Update
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data...
Hematologic Oncology Update
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 3 of a...
Hematologic Oncology Update
What Clinicians Want to Know: Addressing Current Questions and Controversies in...
Hematologic Oncology Update